| Primary |
| Urinary Tract Infection |
16.1% |
| Benign Prostatic Hyperplasia |
14.5% |
| Diarrhoea |
9.7% |
| Bronchitis |
8.1% |
| Multiple Myeloma |
8.1% |
| Prophylaxis Urinary Tract Infection |
8.1% |
| Renal Colic |
8.1% |
| Sepsis |
6.5% |
| Ocular Icterus |
4.8% |
| Prostatitis |
3.2% |
| Pyelonephritis |
3.2% |
| Pyrexia |
3.2% |
| Herpes Virus Infection |
1.6% |
| Infection |
1.6% |
| Meningitis Bacterial |
1.6% |
| Vaginal Infection |
1.6% |
|
| Varicella |
17.2% |
| Drug Exposure During Pregnancy |
10.3% |
| Insomnia |
6.9% |
| International Normalised Ratio Increased |
6.9% |
| Renal Failure Acute |
6.9% |
| Cholestasis |
3.4% |
| Clostridium Difficile Colitis |
3.4% |
| Drug Hypersensitivity |
3.4% |
| Erythema |
3.4% |
| Generalised Oedema |
3.4% |
| Malaise |
3.4% |
| Nausea |
3.4% |
| Neurological Symptom |
3.4% |
| Photosensitivity Reaction |
3.4% |
| Pyrexia |
3.4% |
| Renal Failure |
3.4% |
| Renal Tubular Necrosis |
3.4% |
| Staphylococcal Infection |
3.4% |
| Syncope |
3.4% |
| Tendonitis |
3.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
17.4% |
| Product Used For Unknown Indication |
16.2% |
| Urinary Tract Infection |
15.1% |
| Multiple Myeloma |
7.3% |
| Benign Prostatic Hyperplasia |
6.4% |
| Bronchitis |
5.6% |
| Gastroduodenal Ulcer |
3.9% |
| Helicobacter Gastritis |
3.4% |
| Sepsis |
3.4% |
| Hypertension |
2.2% |
| Pruritus |
2.2% |
| Pyelonephritis Acute |
2.2% |
| Unevaluable Event |
2.2% |
| Anxiety |
2.0% |
| Tonsillitis |
2.0% |
| Diarrhoea |
1.7% |
| Escherichia Infection |
1.7% |
| Glioma |
1.7% |
| Infection Prophylaxis |
1.7% |
| Insomnia |
1.7% |
|
| Varicella |
14.8% |
| Insomnia |
11.1% |
| Tongue Disorder |
7.4% |
| Vomiting |
7.4% |
| Haemolytic Anaemia |
5.6% |
| Renal Failure |
5.6% |
| Renal Failure Acute |
5.6% |
| Thrombocytopenia |
5.6% |
| Bone Marrow Failure |
3.7% |
| Premature Baby |
3.7% |
| Rash |
3.7% |
| Rash Maculo-papular |
3.7% |
| Strabismus |
3.7% |
| Subcutaneous Haematoma |
3.7% |
| Toxic Skin Eruption |
3.7% |
| Vascular Purpura |
3.7% |
| Angioedema |
1.9% |
| Blood Lactate Dehydrogenase Abnormal |
1.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
1.9% |
| Erythema Nodosum |
1.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.0% |
| Urinary Tract Infection |
13.7% |
| Pyelonephritis |
11.0% |
| Multiple Myeloma |
8.7% |
| Product Used For Unknown Indication |
6.8% |
| Bronchitis |
5.7% |
| Rheumatoid Arthritis |
5.3% |
| Benign Prostatic Hyperplasia |
4.2% |
| Hypertension |
3.4% |
| Infection Prophylaxis |
3.0% |
| B-cell Lymphoma |
2.3% |
| Nasopharyngitis |
2.3% |
| Prostate Cancer Metastatic |
2.3% |
| Anxiety |
1.9% |
| Asthma |
1.9% |
| Depression |
1.9% |
| Plasma Cell Myeloma |
1.9% |
| Atrial Fibrillation |
1.5% |
| Cardiac Disorder |
1.5% |
| Psychotic Disorder |
1.5% |
|
| Varicella |
13.2% |
| Henoch-schonlein Purpura |
9.4% |
| Thrombocytopenia |
9.4% |
| Urinary Tract Infection |
7.5% |
| Syncope |
5.7% |
| Vasculitis |
5.7% |
| Vomiting |
5.7% |
| Basal Cell Carcinoma |
3.8% |
| Faecalith |
3.8% |
| Hypoglycaemic Coma |
3.8% |
| Intracranial Haematoma |
3.8% |
| Respiratory Distress |
3.8% |
| Staphylococcal Infection |
3.8% |
| Torsade De Pointes |
3.8% |
| Toxic Skin Eruption |
3.8% |
| Tracheal Fistula |
3.8% |
| Weight Decreased |
3.8% |
| Anxiety |
1.9% |
| Ascites |
1.9% |
| Blood Potassium Decreased |
1.9% |
|
| Interacting |
|
|
